Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin αv‐mediated ADAM activity in hepatocellular carcinoma: A novel functional target for gefitinib

Mitsuhiro Matsuo(Oita University), Ikuo Saiki(University of Toyama)
Cancer Science
January 25, 2006
Cited by 67


Related Papers